Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer source : Investors.senseibio.com save search
Sensei Biotherapeutics to Present New Preclinical Data Supporting Mechanism of Action, Pharmacokinetic Profile and Safety Characteristics for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Seventh CRI-ENCI-AACR International Cancer Immuno
Published: 2023-09-13 (Crawled : 12:30) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: 1.03%
H: 7.87%
C: -1.02%
sns-101 active cancer international preclinical
Sensei Biotherapeutics Presents New Preclinical Data on SNS-103 Targeting ENTPDase1 (CD39) at the American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-04-18 (Crawled : 21:00) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: -2.41%
H: 8.02%
C: 7.41%
sns-103 association cancer research preclinical meeting
Sensei Biotherapeutics to Present New Preclinical Data for SNS-103, a Conditionally Active Monoclonal Antibody Targeting ENTPDase1 (CD39), at the American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-03-14 (Crawled : 21:00) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: -2.08%
H: 0.71%
C: -1.42%
sns-103 research preclinical active antibody meeting association cancer
Sensei Biotherapeutics Presents Preclinical Data at the 37th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2022-11-10 (Crawled : 14:00) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: 2.92%
H: 7.09%
C: 6.38%
preclinical immunotherapy meeting cancer
Sensei Biotherapeutics to Present New Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: 0.0%
H: 2.4%
C: -2.4%
preclinical immunotherapy meeting cancer
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
Published: 2022-09-30 (Crawled : 21:00) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
| Email alert
Add to watchlist
sns-101 preclinical immunotherapy active cancer international
Sensei Biotherapeutics to Present Preclinical Data for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Sixth Annual CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
Published: 2022-09-21 (Crawled : 21:00) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: 0.0%
H: 5.06%
C: 2.25%
sns-101 preclinical immunotherapy active cancer international
Sensei Biotherapeutics Presents Preclinical Data for SNS-101, a pH-Selective Anti-VISTA Antibody, at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 16:20) - investors.senseibio.com
SNSE | $0.96 -3.78% -3.93% 55K
|
|
| O: -1.15%
H: 0.0%
C: 0.0%
preclinical immunotherapy therapy cancer antibody iot pre-clinical
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.